Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?

Journal of Clinical Psychopharmacology

Volumn 29, Issue 6, 2009, Pages 609-611

  Wu, Yelena ^a   Deboeck, Pascal ^b   Joseph, Megan ^a   Hwang, Cindy ^a   Perlis, Clifford S ^a   Perlis, Roy H ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONFLICT OF INTEREST; EMPLOYMENT; HYPOTHESIS; LETTER; LOGISTIC REGRESSION ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PSYCHIATRY; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; HUMANS; PSYCHIATRY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 72949089119     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181bfa4e5     Document Type: Letter

References (15)

1. Bekelman J, Li Y, Gross C. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454-465.
2. Baker CB, Johnsrud MT, Crisman ML, et al. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry. 2003;183:498-506.
3. Perlis RH, Perlis CS, Wu Y, et al. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry. 2005; 162:1957-1960.
4. Okike K, Kocher MS, Mehlman CT, et al. Conflict of interest in orthopaedic research: an association between findings and funding in scientific presentations. J Bone Joint Surg. 2007;89A:608-613.
5. Sismondo S. How pharmaceutical industry funding affects trial outcomes: causal structures and responses. Soc Sci Med. 2008;66:1909-1914.
6. Djulbegovic B, Lacevic M, Cantor A, et al. The uncertainty principle and industry-sponsored research. Lancet. 2000;356:635-638.
7. R [computer program]. Version 2.7.2. Auckland, New Zealand: Statistics Department of the University of Auckland; 2008.
8. Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004; 19:51-56.
9. Montaner JS, O'Shaughnessy MV, Schechter MT. Industry-sponsored clinical research: a double-edged sword. Lancet. 2001;358:1893-1895.
10. Fava GA. Conflict of interest in psychopharmacology: Can Dr. Jekyll still control Mr. Hyde? Psychother Psychosom. 2004;73:1-4.
11. Khan A, Khan S, Brown WA. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmcol. 2002;5:193-197.
12. Doucet M, Sismondo S. Evaluating solutions to sponsorship bias. J Med Ethics. 2008;34:627-630.
13. Yusuf S, Bosch J. Independent design and conduct of clinical trials. Clin Trials. 2006;3:503-507.
14. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006; 295:429-433.
15. Angell M. Drug companies and doctors: a story of corruption. The New York Review of Books Web site. January 15, 2009;56. Available at: http://www.nybooks.com/ articles/22237. Accessed January 17, 2009.